Munich, Germany

Rudolf Reiter

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rudolf Reiter. Retrieved from https://idiyas.com/inventor/rudolf-reiter-crkvz71i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rudolf Reiter: Innovator in Bishispidine Compounds

Introduction

Rudolf Reiter, an accomplished inventor based in Wemheim, Germany, has made significant contributions to the field of pharmaceutical science. With a keen focus on innovative solutions, he has secured one patent, solidifying his status as a noteworthy figure in the industry.

Latest Patents

Rudolf Reiter's most notable patent is centered around Bishispidine compounds and the processes for their production. This invention holds potential implications for various applications within the pharmaceutical sector, showcasing Reiter's commitment to advancing medicinal chemistry.

Career Highlights

Currently, Rudolf Reiter is associated with Boehringer Mannheim GmbH, a leading company in the pharmaceutical industry. His work at the firm reflects his dedication to research and development, as he strives to create impactful innovations that enhance healthcare solutions.

Collaborations

Throughout his career, Reiter has collaborated closely with talented colleagues, including Edgar Voss and Claus Kilpert. These partnerships have fostered an environment of creativity and innovation, contributing to the successful development of cutting-edge pharmaceutical products.

Conclusion

Rudolf Reiter exemplifies the spirit of innovation within the pharmaceutical landscape. His contributions through his patent on Bishispidine compounds highlight the importance of teamwork and collaboration in driving advancement. As he continues his work at Boehringer Mannheim GmbH, the future looks promising for further breakthroughs in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…